Aneurisk is focused on advancing aneurysm care through a single platform that combines advanced medical imaging and predictive modeling to help doctors better understand and predict risk. It begins with tools for aortic aneurysm assessment and is designed to support clearer diagnoses, ongoing monitoring, and smarter treatment decisions.
Learn More
Focused on advancing eye care, Netramind Innovations uses advanced software and AI to analyze eye images and help doctors spot problems more clearly. Their tools turn scans and photos of the eye into useful insights that support better diagnosis and patient care.
Learn More
Malleous aims to develop a groundbreaking neurosurgical device, licensed from Pitt, that promises to enhance open brain surgery procedures by increasing safety, efficiency and patient outcomes.
Learn More
Despite it being such a common issue, treatment options for chronic pain are not one-size-fits-all. The Personalized Pain Treatment™ project uses machine learning to predict patients’ unique responses to various pain treatments.
Learn More
Taja Health makes science-based digital tools that help people change habits and thinking patterns as part of mental health care. Their products are designed to work alongside treatments like medication or ketamine, taking advantage of short windows when the brain is more open to positive change.
Learn More
Roc the Panther prowled the sidelines as the anticipation grew inside the Petersen Events Center while the starting lineup was announced.
But the five all-stars who donned their Pitt caps after signing their commitment letters weren’t the most recent recruits to the Pitt basketball or volleyball teams. They were faculty, students, and clinicians eager to change the game in their respective fields by translating their research discoveries from the lab to the market, where they can make a difference in people’s lives.
The University of Pittsburgh held its first-ever Signing Day for Startups on Nov. 7, 2024, celebrating researchers who have turned their lab discoveries into startup companies. The event highlighted five innovators leading ventures in areas like cancer therapies, wound care, chronic pain devices, and diagnostic tools, showcasing Pitt’s growing support for research commercialization.
A team of University of Pittsburgh researchers is developing a biodegradable nerve stimulator through their startup Vanish Therapeutics to offer safer, non‑addictive treatment for chronic pain, potentially reducing reliance on opioids and invasive implants.
Read More
Zegenex is a Pittsburgh‑based biotechnology startup spun out of University of Pittsburgh research that’s developing novel wound‑healing therapies based on molecules identified using regenerative biology studies in zebrafish.
Read More
OIE supports innovators beyond IP protection—offering guidance on patents, startup formation, industry partnerships, and access to funding opportunities that help move ideas from discovery to impact.
